Novarel
NOVAREL (chorionic gonadotropin) for injection, for intramuscular use Initial U.S. Approval: 1974
Approved
Approval ID
ac6918ff-9dc3-40d9-8619-54b26e4bdfc8
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 5, 2023
Manufacturers
FDA
Ferring Pharmaceuticals Inc.
DUNS: 103722955
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
gonadotrophin, chorionic
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code55566-1502
Application NumberBLA017016
Product Classification
M
Marketing Category
C73585
G
Generic Name
gonadotrophin, chorionic
Product Specifications
Effective DateJune 5, 2023
FDA Product Classification
gonadotrophin, chorionic
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code55566-1501
Application NumberBLA017016
Product Classification
M
Marketing Category
C73585
G
Generic Name
gonadotrophin, chorionic
Product Specifications
Effective DateJune 5, 2023
FDA Product Classification